UFPT — UFP Technologies Inc. stock price and chart

UFPT

$291.34-0.65%

as of close, Oct 20, 2026

☾ AH $291.34 -0.65%

UFP Technologies Inc.Stock · HealthcareRussell 2000 · 0.06% of IWMNasdaq Composite · 0.006% of ONEQRussell 3000 · 0.003% of IWVUS Stock Market · 0.003% of VTI

PeersMRNALLYMDTUNHJNJTMO

Share this page

Technical analysis2

Overlay lines0

Addendum charts0

VolumeEEEEEEEEEEEE

20162019202120242026

50.0100.0150.0200.0250.0300.001.0M2.0M$291.34

2026-10-20

Price$291.34

MA20$267.40

MA50$236.43

Vol410.5K

What would $1,000 invested in UFPT be worth today? →

UFPT returns: By year · By month · By week · Trailing

Key stats#

Price data

Price: $291.34
YTD price return: +31.22%
YTD total return: +31.22%
Next earnings: Nov 2, 2026
Market cap: 2.3B2016-12 184M2026-10 2.3B+1126.8% over the window
Enterprise value: 2.4B
Shares outstanding: 7.7M2016-06 7.2M2026-06 7.7M+7.2% over the window
52W low: $173.86
52W high: $338.71
From 52W high: -13.99%
From 52W low: +67.57%
52W range: 71%

Volume

Rel volume: 1.17×
30D volume: 110.7K
30D $ vol: 32.1M

Fundamentals

Sales (ttm): 631.6M2016-06 140.8M2026-06 631.6M+348.7% over the window
Sales/share: $81.552016-06 $19.492026-06 $81.55+318.4% over the window
EPS (ttm): $9.282016-06 $1.042026-06 $9.28+792.3% over the window
FCF (ttm): 91.9M2015-12 -3.2M2025-12 91.9M-2951.5% over the window
FCF/share: $11.872015-12 -$0.452025-12 $11.92-2753.8% over the window
Book value/share: $59.702016-06 $15.022026-06 $59.70+297.4% over the window
Net margin: 11.45%2016-06 5.3%2026-06 11.4%+115.5% over the window
ROE: 15.63%2016-06 6.9%2026-06 15.6%+126.9% over the window
ROA: 10.60%2016-06 6.0%2026-06 10.6%+77.2% over the window
Debt / equity: 0.23×2016-06 0.002026-06 0.23+7028.4% over the window
Current ratio: 3.002016-06 5.952026-06 3.00-49.6% over the window

Growth (CAGR, ttm) · 10Y

Sales: +7.32%2025-06-30 → 2026-06-30588.6M → 631.6M (+7.3% total)+17.84%2023-06-30 → 2026-06-30386M → 631.6M (+63.6% total)+27.47%2021-06-30 → 2026-06-30187.7M → 631.6M (+236.5% total)+16.20%2016-06-30 → 2026-06-30140.8M → 631.6M (+348.7% total)
Net income: +7.75%2025-06-30 → 2026-06-3067.1M → 72.3M (+7.7% total)+13.36%2023-06-30 → 2026-06-3049.6M → 72.3M (+45.7% total)+35.15%2021-06-30 → 2026-06-3016M → 72.3M (+350.8% total)+25.47%2016-06-30 → 2026-06-307.5M → 72.3M (+866.8% total)
FCF: +61.47%2024-12-31 → 2025-12-3156.9M → 91.9M (+61.4% total)+185.08%2022-12-31 → 2025-12-314M → 91.9M (+2218.5% total)+34.78%2020-12-31 → 2025-12-3120.7M → 91.9M (+344.7% total)n/a
Shares: +0.45%2025-06-30 → 2026-06-307.7M → 7.7M (+0.4% total)+0.46%2023-06-30 → 2026-06-307.6M → 7.7M (+1.4% total)+0.56%2021-06-30 → 2026-06-307.5M → 7.7M (+2.8% total)+0.70%2016-06-30 → 2026-06-307.2M → 7.7M (+7.2% total)

Per-share growth (CAGR, ttm) · 10Y

EPS: +7.54%2025-06-30 → 2026-06-30$8.63 → $9.28 (+7.5% total)+12.71%2023-06-30 → 2026-06-30$6.48 → $9.28 (+43.2% total)+34.36%2021-06-30 → 2026-06-30$2.12 → $9.28 (+337.7% total)+24.47%2016-06-30 → 2026-06-30$1.04 → $9.28 (+792.3% total)
Sales/share: +6.84%2025-06-30 → 2026-06-30$76.33 → $81.55 (+6.8% total)+17.29%2023-06-30 → 2026-06-30$50.53 → $81.55 (+61.4% total)+26.76%2021-06-30 → 2026-06-30$24.92 → $81.55 (+227.2% total)+15.39%2016-06-30 → 2026-06-30$19.49 → $81.55 (+318.4% total)
FCF/share: +60.78%2024-12-31 → 2025-12-31$7.41 → $11.92 (+60.7% total)+183.80%2022-12-31 → 2025-12-31$0.52 → $11.92 (+2187.5% total)+34.10%2020-12-31 → 2025-12-31$2.75 → $11.92 (+333.5% total)n/a
Book value/share: +19.44%2025-06-30 → 2026-06-30$49.99 → $59.70 (+19.4% total)+20.55%2023-06-30 → 2026-06-30$34.07 → $59.70 (+75.2% total)+19.27%2021-06-30 → 2026-06-30$24.74 → $59.70 (+141.3% total)+14.80%2016-06-30 → 2026-06-30$15.02 → $59.70 (+297.4% total)
Price: +47.73%2025-10-20 → 2026-10-20$197.26 → $291.34 (+47.7% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+23.94%2023-10-20 → 2026-10-20$152.99 → $291.34 (+90.4% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+35.84%2021-10-20 → 2026-10-20$63.00 → $291.34 (+362.4% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+27.09%2016-10-19 → 2026-10-20$26.50 → $291.34 (+999.4% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.
Total return: +47.73%2025-10-20 → 2026-10-20$197.26 → $291.34 (+47.7% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+23.94%2023-10-20 → 2026-10-20$152.99 → $291.34 (+90.4% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+35.84%2021-10-20 → 2026-10-20$63.00 → $291.34 (+362.4% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+27.09%2016-10-19 → 2026-10-20$26.50 → $291.34 (+999.4% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: 31.4×2016-12 22.562026-10 31.21+38.4% over the window
P/OI (ttm)Price ÷ TTM operating income. Excludes the below-the-line items that make P/E jump — mark-to-market gains, settlements, tax true-ups.: 23.4×2016-12 14.622026-10 23.42+60.2% over the window
Fwd P/E: 24.7×
P/S (ttm)Market cap ÷ TTM revenue.: 3.6×2016-12 1.282026-10 3.57+178.8% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 4.9×2016-12 1.652026-10 4.88+195.8% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 24.6×2016-12 -57.082026-10 24.55-143.0% over the window
EV/EBITDA (fy): 20.5×
EV/Sales (ttm): 3.8×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 4.07%2016-12 1.1%2025-12 5.4%+370.1% over the window
Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 7.7M ÷ 7.7M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: -0.45%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-0.45%) + dividends paid over that year ($0) ÷ market_cap_at(2025-06-30) ($1.9B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: -0.45%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($0) ÷ today's market cap ($2.3B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 0.00%2016-09 0.0%2026-06 0.0%
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $0 + TTM dividends $0) ÷ today's market cap ($2.3B). Same caveat as the cash buyback yield.: 0.00%2016-09 0.0%2026-06 0.0%

Vs own 10Y history

P/E: 80th
P/OI: 78th
P/S: 87th
P/B: 83rd
P/FCF: 45th

Bar = where today’s multiple sits in UFPT’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-10-20#

-0.65%

-1.00%

+5.29%

+18.62%

YTD

+31.22%

+47.69%

+362.44%

Financial statements

Open full UFPT financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	+11.34%	+3.49%
JNJ	Johnson & Johnson	-3.94%	+2.19%
ABBV	AbbVie Inc.	+9.52%	+2.26%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	+11.24%	+3.04%
MRK	Merck & Co. Inc.	+0.97%	+3.25%
NVS	Novartis AG	+9.45%	+2.29%
TMO	Thermo Fisher Scientific Inc.	+5.51%	+1.18%
AMGN	Amgen Inc.	+13.82%	+3.29%

UFPT — UFP Technologies Inc. price, chart and key statistics